Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
PHASE2
This study targets an adult population of patients with recurrent or metast...
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
PHASE2
The purpose of this study is to evaluate the effectiveness and safety of re...
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
PHASE1
This is a Phase 1B study assessing the safety of immune checkpoint inhibiti...
A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Least One Prior Chemotherapy-based Treatment by Lung Initiative on Sequence Therapy
N/A
The purpose of this trial is to describe the following, for each cohort, in...
Status
Completed
Location
Local Institution - 0001
Start Date
2020-09-28
Trial ID
NCT04500535
Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination
N/A
This study will collect real-world data for the new treatment pathways for ...